LanthaGen Bio
PrivateLast Round
Pre Seed
May 1, 2026
Total Funding Raised
$1.72M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
LanthaGen Bio operates in Energy & Sustainability and is based in Manchester. Its latest recorded funding round was a Grant round in December 2025.
LanthaGen Bio is a biotechnology company that develops synthetic biology-based systems for the selective extraction and recovery of rare earth and precious metals from industrial waste streams.
Sector
Energy & Sustainability
Verticals
Biotechnology, Circular Economy, Waste Management
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LanthaGen Bio Comparables
Compare LanthaGen Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RareTerra | 87% | |
| CaptuREE | 86% | |
| Infinite Elements, Inc. | 85% |
For institutional investors. Book with your work email.
LanthaGen Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 1, 2026 | ||||
| Grant | Dec 1, 2025 | ||||
| Grant | Jul 14, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
LanthaGen Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The University of Manchester | Grant |
| SPRIND | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
Completed a Pre Seed funding round.
- Dec 1, 2025
$1.62M grant received from SPRIND.
For institutional investors. Book with your work email.
LanthaGen Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LanthaGen Bio's valuation, stock price, and market status.
Is LanthaGen Bio a public or private company?
LanthaGen Bio is a private company.
What is the current stock price of LanthaGen Bio?
LanthaGen Bio is a private company, so its shares have no public market price. Caplight tracks LanthaGen Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LanthaGen Bio worth (valuation)?
Valuation information for LanthaGen Bio is not publicly available.
Can I buy LanthaGen Bio stock?
LanthaGen Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LanthaGen Bio's last funding round?
LanthaGen Bio's most recent funding round was Pre Seed on May 1, 2026.
Who are the main investors in LanthaGen Bio?
Key investors in LanthaGen Bio include The University of Manchester, SPRIND.
Will LanthaGen Bio IPO soon?
No public IPO plans have been announced for LanthaGen Bio.
How can I track LanthaGen Bio secondary market activity?
Caplight tracks bids, offers, and trades in LanthaGen Bio's shares on secondary markets.